FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2513940906> ?p ?o ?g. }

• W2513940906 endingPage "1452" @default.
• W2513940906 startingPage "1445" @default.
• W2513940906 abstract "BackgroundCervical cancer incidence remains high in several Baltic, central, and eastern European (BCEE) countries, mainly as a result of a historical absence of effective screening programmes. As a catalyst for action, we aimed to estimate the number of women who could be spared from cervical cancer across six countries in the region during the next 25 years, if effective screening interventions were introduced.MethodsIn this population-based study, we applied age–period–cohort models with spline functions within a Bayesian framework to incidence data from six BCEE countries (Estonia, Latvia, Lithuania, Belarus, Bulgaria, and Russia) to develop projections of the future number of new cases of cervical cancer from 2017 to 2040 based on two future scenarios: continued absence of screening (scenario A) versus the introduction of effective screening from 2017 onwards (scenario B). The timespan of available data varied from 16 years in Bulgaria to 40 years in Estonia. Projected rates up to 2040 were obtained in scenario A by extrapolating cohort-specific trends, a marker of changing risk of human papillomavirus (HPV) infection, assuming a continued absence of effective screening in future years. Scenario B added the effect of gradual introduction of screening in each country, under the assumption period effects would be equivalent to the decreasing trend by calendar year seen in Denmark (our comparator country) since the progressive regional introduction of screening from the late 1960s.FindingsAccording to scenario A, projected incidence rates will continue to increase substantially in many BCEE countries. Very high age-standardised rates of cervical cancer are predicted in Lithuania, Latvia, Belarus, and Estonia (up to 88 cases per 100 000). According to scenario B, the beneficial effects of effective screening will increase progressively over time, leading to a 50–60% reduction of the projected incidence rates by around 2040, resulting in the prevention of cervical cancer in 1500 women in Estonia and more than 150 000 women in Russia. The immediate launch of effective screening programmes could prevent almost 180 000 new cervical cancer diagnoses in a 25-year period in the six BCEE countries studied.InterpretationBased on our findings, there is a clear need to begin cervical screening in these six countries as soon as possible to reduce the high and increasing incidence of cervical cancer over the next decades.FundingNone." @default.
• W2513940906 created "2016-09-16" @default.
• W2513940906 creator A5001857260 @default.
• W2513940906 creator A5037728205 @default.
• W2513940906 creator A5046598264 @default.
• W2513940906 creator A5052426492 @default.
• W2513940906 creator A5062790218 @default.
• W2513940906 creator A5064215217 @default.
• W2513940906 creator A5071864458 @default.
• W2513940906 date "2016-10-01" @default.
• W2513940906 modified "2023-10-16" @default.
• W2513940906 title "Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study" @default.
• W2513940906 cites W1275532855 @default.
• W2513940906 cites W1757407923 @default.
• W2513940906 cites W1928716358 @default.
• W2513940906 cites W1964611184 @default.
• W2513940906 cites W1972678560 @default.
• W2513940906 cites W1981029526 @default.
• W2513940906 cites W1995961263 @default.
• W2513940906 cites W1998209006 @default.
• W2513940906 cites W2014170457 @default.
• W2513940906 cites W2021052809 @default.
• W2513940906 cites W2027715074 @default.
• W2513940906 cites W2028268806 @default.
• W2513940906 cites W2029287782 @default.
• W2513940906 cites W2040233643 @default.
• W2513940906 cites W2071404141 @default.
• W2513940906 cites W2072633261 @default.
• W2513940906 cites W2074150889 @default.
• W2513940906 cites W2075876980 @default.
• W2513940906 cites W2079172413 @default.
• W2513940906 cites W2079458026 @default.
• W2513940906 cites W2082555938 @default.
• W2513940906 cites W2100234656 @default.
• W2513940906 cites W2101824215 @default.
• W2513940906 cites W2107703091 @default.
• W2513940906 cites W2117315162 @default.
• W2513940906 cites W2123323832 @default.
• W2513940906 cites W2124387763 @default.
• W2513940906 cites W2133830458 @default.
• W2513940906 cites W2138556740 @default.
• W2513940906 cites W2141926583 @default.
• W2513940906 cites W2144233397 @default.
• W2513940906 cites W2148969651 @default.
• W2513940906 cites W2151780198 @default.
• W2513940906 cites W2163308724 @default.
• W2513940906 cites W2183987150 @default.
• W2513940906 cites W2327854357 @default.
• W2513940906 cites W25535114 @default.
• W2513940906 doi "https://doi.org/10.1016/s1470-2045(16)30275-3" @default.
• W2513940906 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5052457" @default.
• W2513940906 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27567054" @default.
• W2513940906 hasPublicationYear "2016" @default.
• W2513940906 type Work @default.
• W2513940906 sameAs 2513940906 @default.
• W2513940906 citedByCount "66" @default.
• W2513940906 countsByYear W25139409062016 @default.
• W2513940906 countsByYear W25139409062017 @default.
• W2513940906 countsByYear W25139409062018 @default.
• W2513940906 countsByYear W25139409062019 @default.
• W2513940906 countsByYear W25139409062020 @default.
• W2513940906 countsByYear W25139409062021 @default.
• W2513940906 countsByYear W25139409062022 @default.
• W2513940906 countsByYear W25139409062023 @default.
• W2513940906 crossrefType "journal-article" @default.
• W2513940906 hasAuthorship W2513940906A5001857260 @default.
• W2513940906 hasAuthorship W2513940906A5037728205 @default.
• W2513940906 hasAuthorship W2513940906A5046598264 @default.
• W2513940906 hasAuthorship W2513940906A5052426492 @default.
• W2513940906 hasAuthorship W2513940906A5062790218 @default.
• W2513940906 hasAuthorship W2513940906A5064215217 @default.
• W2513940906 hasAuthorship W2513940906A5071864458 @default.
• W2513940906 hasBestOaLocation W25139409061 @default.
• W2513940906 hasConcept C118552586 @default.
• W2513940906 hasConcept C120665830 @default.
• W2513940906 hasConcept C121332964 @default.
• W2513940906 hasConcept C121608353 @default.
• W2513940906 hasConcept C126322002 @default.
• W2513940906 hasConcept C144024400 @default.
• W2513940906 hasConcept C149923435 @default.
• W2513940906 hasConcept C27415008 @default.
• W2513940906 hasConcept C2778220009 @default.
• W2513940906 hasConcept C2780647465 @default.
• W2513940906 hasConcept C2908647359 @default.
• W2513940906 hasConcept C49388559 @default.
• W2513940906 hasConcept C61511704 @default.
• W2513940906 hasConcept C71924100 @default.
• W2513940906 hasConcept C72563966 @default.
• W2513940906 hasConcept C77352025 @default.
• W2513940906 hasConcept C99454951 @default.
• W2513940906 hasConceptScore W2513940906C118552586 @default.
• W2513940906 hasConceptScore W2513940906C120665830 @default.
• W2513940906 hasConceptScore W2513940906C121332964 @default.
• W2513940906 hasConceptScore W2513940906C121608353 @default.
• W2513940906 hasConceptScore W2513940906C126322002 @default.
• W2513940906 hasConceptScore W2513940906C144024400 @default.
• W2513940906 hasConceptScore W2513940906C149923435 @default.
• W2513940906 hasConceptScore W2513940906C27415008 @default.

• next